Skip to main content
. 2009 Jan;126(1):132–139. doi: 10.1111/j.1365-2567.2008.02886.x

Table 1.

Antibodies used

Specificity Clone Isotype Conjugate Dilution Supplier
CD6 Ox 52 IgG2a, κ Unconjugated 1 : 2000 Serotec1
T lymphocytes (α/β) R73 IgG1 Unconjugated 1 : 20 Serotec
MHC class II Ox 6 IgG1 Biotinylated 1 : 50 Serotec
CD4 W3/25 IgG1 Biotinylated FITC APC 1 : 100 1 : 1000 1 : 250 Serotec
CD25 Ox 39 IgG1 Biotinylated PE 1 : 50 1 : 50 Serotec
Neuropilin 1 (Nrp1) 130604 IgG1 Unconjugated 1 : 100 RD Systems2
Isotope control for Nrp1 IgG1 Unconjugated 1 : 100 RD Systems3
Foxp3 FJK-16s IgG2a, κ FITC 1 : 10 BioLegend4
Isotype control for Foxp3 (mAB) IgG2a FITC 1 : 10 BioLegend
B cells [F (ab) fragment of rat IgG] Ox 12 IgG1 Unconjugated 1 : 1000 Serotec
Monocytes, macrophages, DCs, granulocytes ED9 IgG1 Unconjugated 1 : 500 Serotec
NK cells CD161 100/78 Unconjugated 1 : 500 Serotec
1

Kidlington, Oxford, UK;

2

Abington, Oxford, UK;

3

Wiesbdaen, Germany;

4

San Diego, CA.

DC, dendritic cell; IgG, immunoglobulin G; mAb, monoclonal antibody; MHC, major histocompatibility complex; NK, natural killer.